TA
Thomas A Armer
Chief Scientific OfficerDirector

Thomas A Armer insider trades: MAP Pharmaceuticals (MAPP) stock sales

Chief Scientific Officer, MAP Pharmaceuticals Last trade Jan 23, 2013 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2009
1
Company
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 23, 2013MAPP↓ Sell$1.5M
Feb 14, 2012MAPP↓ Sell$529K
Feb 8, 2012MAPP↓ Sell$419K
Feb 6, 2012MAPP↓ Sell$300K
Dec 19, 2011MAPP↓ Sell$280K
Mar 4, 2011MAPP↓ Sell$483K
Dec 14, 2009MAPP↓ Sell$95K
May 27, 2009MAPP↓ Sell$961K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas A Armer's insider trades

Thomas A Armer is Chief Scientific Officer at MAP Pharmaceuticals (MAPP). Since May 27, 2009, Thomas has reported no open-market purchases and 8 sales worth $4.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (6 filings), grants and awards (5 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.